Change of Corporate Broker

In brief · summary, not quotable

Cizzle Biotechnology Holdings PLC has appointed Zeus Capital Limited as its sole Corporate Broker, effective immediately. This change in brokerage is a significant development for the company, which is focused on developing a non-invasive blood test for early lung cancer detection using the CIZ1B biomarker. The company has recently entered into commercial royalty-bearing arrangements and collaborations to advance its proprietary technology.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your CIZ notes

Cizzle Biotechnology is pleased to announce the appointment of Zeus Capital Limited as the Company's sole Corporate Broker with immediate effect.

You can also follow the Company through its twitter account @CizzlePlc and on LinkedIn.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.